
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epidemiology, Screening, and Prevention of Bladder Cancer
Niyati Lobo, Luca Afferi, Marco Moschini, et al.
European Urology Oncology (2022) Vol. 5, Iss. 6, pp. 628-639
Closed Access | Times Cited: 187
Niyati Lobo, Luca Afferi, Marco Moschini, et al.
European Urology Oncology (2022) Vol. 5, Iss. 6, pp. 628-639
Closed Access | Times Cited: 187
Showing 26-50 of 187 citing articles:
Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the global burden of disease study 2021
Xingyang Su, Yifang Tao, Feng Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Xingyang Su, Yifang Tao, Feng Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Leveraging Deep Learning in Real-Time Intelligent Bladder Tumor Detection During Cystoscopy: A Diagnostic Study
Zixing Ye, Yingjie Li, Yujiao Sun, et al.
Annals of Surgical Oncology (2025)
Open Access
Zixing Ye, Yingjie Li, Yujiao Sun, et al.
Annals of Surgical Oncology (2025)
Open Access
Molecular testing in urinary cytology specimens: Current status and future directions
Fei Chen, Aylin Simsir, Liang Cheng
Urologic Oncology Seminars and Original Investigations (2025)
Closed Access
Fei Chen, Aylin Simsir, Liang Cheng
Urologic Oncology Seminars and Original Investigations (2025)
Closed Access
Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Ádám Széles, András Kubik, Szilárd Váncsa, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ádám Széles, András Kubik, Szilárd Váncsa, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Bladder Cancer in Lebanon: An Updated Epidemiological Comparison with Global Regions and a Comprehensive Review of Risk Factors
Najla A. Lakkis, Mona H. Osman, Reem Abdallah, et al.
Cancer Control (2025) Vol. 32
Open Access
Najla A. Lakkis, Mona H. Osman, Reem Abdallah, et al.
Cancer Control (2025) Vol. 32
Open Access
Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations
Hye Won Lee, Whi‐An Kwon, La Ngoc Thu Nguyen, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1323-1323
Open Access | Times Cited: 11
Hye Won Lee, Whi‐An Kwon, La Ngoc Thu Nguyen, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1323-1323
Open Access | Times Cited: 11
Role of human papillomavirus and associated viruses in bladder cancer: An updated review
Xiangyang Yao, Zhenzhen Xu, Chen Duan, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Open Access | Times Cited: 11
Xiangyang Yao, Zhenzhen Xu, Chen Duan, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Open Access | Times Cited: 11
Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis
Zhouting Tuo, Dechao Feng, Zhiwei Jiang, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 6, pp. 686-701
Open Access | Times Cited: 11
Zhouting Tuo, Dechao Feng, Zhiwei Jiang, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 6, pp. 686-701
Open Access | Times Cited: 11
A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study
Zongjie Wei, Yingjie Xv, Huayun Liu, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 4
Zongjie Wei, Yingjie Xv, Huayun Liu, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 4
The effect of race/ethnicity on cancer-specific mortality after trimodal therapy
Mario de Angelis, Andrea Baudo, Carolin Siech, et al.
Journal of Racial and Ethnic Health Disparities (2024)
Closed Access | Times Cited: 4
Mario de Angelis, Andrea Baudo, Carolin Siech, et al.
Journal of Racial and Ethnic Health Disparities (2024)
Closed Access | Times Cited: 4
Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Priyanka Yolmo, Sadaf Rahimi, Stephen Chenard, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 10, pp. 1320-1339
Open Access | Times Cited: 4
Priyanka Yolmo, Sadaf Rahimi, Stephen Chenard, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 10, pp. 1320-1339
Open Access | Times Cited: 4
A radiomics-based interpretable machine learning model to predict the HER2 status in bladder cancer: a multicenter study
Zongjie Wei, Xuesong Bai, Yingjie Xv, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Zongjie Wei, Xuesong Bai, Yingjie Xv, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Prospective Assessment of VI-RADS with Muscle Invasion in Urinary Bladder Cancer and Its Implication on Re-Resection/Restaging TURBT Patients
Sukhad Kural, Abhay Kumar Pathak, Shweta Singh, et al.
Annals of Surgical Oncology (2024)
Closed Access | Times Cited: 4
Sukhad Kural, Abhay Kumar Pathak, Shweta Singh, et al.
Annals of Surgical Oncology (2024)
Closed Access | Times Cited: 4
Environmental Exposures and Canine Bladder Cancer: A Case Control Study Using Silicone Passive Samplers
Catherine F. Wise, Nicholas J. Herkert, Kate Hoffman, et al.
Environmental Science & Technology (2025)
Closed Access
Catherine F. Wise, Nicholas J. Herkert, Kate Hoffman, et al.
Environmental Science & Technology (2025)
Closed Access
CDCA4 promotes bladder cancer progression by JAK/STAT signaling pathway
Peng Wan, Yuan Ren, Hao Deng, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access
Peng Wan, Yuan Ren, Hao Deng, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access
Predictive role of lactylation-related gene signature in the prognosis and immunotherapy response in bladder cancer
Guoyuan Liu, Ting Hong, Xinyu Liu, et al.
Archivio Italiano di Urologia e Andrologia (2025)
Open Access
Guoyuan Liu, Ting Hong, Xinyu Liu, et al.
Archivio Italiano di Urologia e Andrologia (2025)
Open Access
TCF7 functions as a prognostic biomarker in bladder cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling
Congcong Zhang, Haiping Cai, Meng‐nan Ye, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Congcong Zhang, Haiping Cai, Meng‐nan Ye, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
ENPP1 Promotes Immune Suppression, Drug Resistance, and Adverse Outcomes in Bladder Cancer: Potential for Targeted Therapy
Chengyu You, Qixiang Fang, Xi Xiao, et al.
Cancer Genetics (2025) Vol. 294-295, pp. 1-14
Closed Access
Chengyu You, Qixiang Fang, Xi Xiao, et al.
Cancer Genetics (2025) Vol. 294-295, pp. 1-14
Closed Access
The interplay between angiogenesis-associated genes and molecular, clinical, and immune features in bladder cancer
Xiaoxiao Guo, Jingxin Yang, Rui Cao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Xiaoxiao Guo, Jingxin Yang, Rui Cao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Repurposing ProTAME for Bladder Cancer: A Combined Therapeutic Approach Targeting Cell Migration and MMP Regulation
İhsan Nalkıran, Hatice Sevim Nalkıran
Biology (2025) Vol. 14, Iss. 3, pp. 263-263
Open Access
İhsan Nalkıran, Hatice Sevim Nalkıran
Biology (2025) Vol. 14, Iss. 3, pp. 263-263
Open Access
CDCA8 and its multifaceted role in tumorigenesis
Bo Peng, Jianquan Zhang, Yang Xiang
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117951-117951
Closed Access
Bo Peng, Jianquan Zhang, Yang Xiang
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117951-117951
Closed Access
The role of urinary microbiota in primary and recurrent bladder cancer: insights from a propensity score matching study
Zhuping Sheng, Jinshan Xu, Maoyu Wang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Zhuping Sheng, Jinshan Xu, Maoyu Wang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
USP5 Suppresses Ferroptosis in Bladder Cancer Through Stabilization of GPX4
Caiying Liu, Yanong Deng, Liang Huang, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 211-211
Open Access
Caiying Liu, Yanong Deng, Liang Huang, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 211-211
Open Access
Acute kidney disease after radical cystectomy for bladder cancer: a new onco‐nephrological view
Francesco Trevisani, Matteo Floris, Mattia Longoni, et al.
BJU International (2025)
Closed Access
Francesco Trevisani, Matteo Floris, Mattia Longoni, et al.
BJU International (2025)
Closed Access
Identification and characterization of tubulin as Ga(III)-binding protein in T24 cells
J. . Chen, Xue Yang, Shaobin Jia, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116842-116842
Closed Access
J. . Chen, Xue Yang, Shaobin Jia, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116842-116842
Closed Access